Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
2022 · Cancer Discovery · 339 citations
https://doi.org/10.1158/2159-8290.cd-22-1066
S
Samantha B. Kemp
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
438
Papers
3.3K
Citations
19
h-index
21
i10-index
Samantha B. Kemp is an academic researcher from University of Michigan. The author has contributed to research in topics: Immune cells in cancer & Phagocytosis and Immune Regulation & Pancreatic and Hepatic Oncology Research. The author has an h-index of 19, co-authored 373 publications.
ORCID: 0000-0002-1505-4015Papers by this author
worksTumour-selective activity of RAS-GTP inhibition in pancreatic cancer
2024 · Nature · 157 citations
https://doi.org/10.1038/s41586-024-07379-z
The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice
2020 · Cellular and Molecular Gastroenterology and Hepatology · 34 citations
https://doi.org/10.1016/j.jcmgh.2020.08.011
Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+ Fibroblasts and Basal Subtype Tumor Cells
2024 · Clinical Cancer Research · 33 citations
https://doi.org/10.1158/1078-0432.ccr-24-2183
T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma
2025 · Cancer Discovery · 26 citations
https://doi.org/10.1158/2159-8290.cd-24-1475
Primary and metastatic cellular landscapes in human pancreatic cancer
2025 · iScience · 2 citations
https://doi.org/10.1016/j.isci.2025.113012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat